Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia

Transfusion

Volumn 51, Issue 7, 2011, Pages 1546-1555

  Serrano Lõpez, Juana ^a   Sanchez Garcia, Joaquin ^a   Serrano, Josefina ^a   Alvarez Rivas, Miguel A ^a   Garcia Castellano, Jose M ^a   Roman Gomez, Jose ^a   Rosa, Olga De La ^a   Herrera Arroyo, Concepcion ^a   Torres Gomez, Antonio ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CELL LYSATE; CELL MATURATION; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

CELL CULTURE TECHNIQUES; DENDRITIC CELLS; FEASIBILITY STUDIES; GRAFT VS LEUKEMIA EFFECT; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOTHERAPY; LEUKEMIA, MYELOID, ACUTE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TUMOR CELLS, CULTURED;

EID: 79960173587     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03042.x     Document Type: Article

References (39)

1. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD, European LeukemiaNet. Diagnosis and management of acute myeloid leukemia in adults: recommendations from and international expert panel, on behalf of the European Leukemia Net. Blood 2010; 115: 453-574.
2. Breems DA, Lowanberg B,. Acute myeloid leukemia and the position of autologous stem cell transplantation. Semin Hematol 2007; 44: 259-66. (Pubitemid 47599543)
3. Greiner J, Dohner H, Schmitt M,. Cancer vaccines for patients with acute myeloid leukaemia: definition of leukaemia-associated antigens and current clinical protocols targeting these antigens. Haematologica 2006; 91: 1653-61. (Pubitemid 46039635)
4. Montagna D, Maccario R, Locatelli F,. Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukaemia. Blood 2006; 108: 3843-50. (Pubitemid 44864567)
5. Banchereau J, Palucka K,. Dendritic cells as therapeutic vaccines against cancer. Nat Rev 2005; 5: 296-306. (Pubitemid 40516155)
6. O'Neill DW, Adams S, Bhardwaj N,. Manipulating dendritic cells biology for the active immunotherapy of cancer. Blood 2004; 104: 2235-46. (Pubitemid 39331818)
7. Banchereau J, Steinman RM,. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52. (Pubitemid 28155090)
8. Hart DNJ,. Dendritic cells: unique leukocyte population which controls the primary immune response. Blood 1997; 90: 3245-87. (Pubitemid 27473395)
9. MacDonald KP, Munster DJ, Clark GJ,. Characterization of human blood dendritic cell subsets. Blood 2002; 100: 4512-20. (Pubitemid 35429692)
10. Banchereau J, Briere F, Caux C,. Immunobiology of dendritic cells. Ann Rev Immunol 2000; 18: 767-811. (Pubitemid 30365397)
11. Blom B, Lighart SJ, Schotte R,. Development origin of pre-DC2. Human Immunol 2002; 63: 1072-80.
12. Gilliet M, Liu YJ,. Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Human Immunol 2002; 63: 1149-55. (Pubitemid 36025989)
13. Houtenbos I, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA,. Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia. Haematologica 2006; 91: 348-55.
14. Choudhury A, Liang JC, Thomas EK,. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous antileukemic T-cell responses. Blood 1999; 93: 780-6. (Pubitemid 29067842)
15. Harrison BD, Adams JA, Briggs M, Brereton ML, Yin JA,. Stimulation of autologous proliferative and cytotoxic T-cell responses by leukemic dendritic cells derived from blast cells in acute myeloid leukemia. Blood 2001; 97: 2764-71.
16. Li L, Reinshardt P, Hus I,. Dendritic cells generated from AML blasts express leukemia associated antigens eliciting specific cytotoxic T cell responses in the autologous host after DC vaccination. Blood 2004; 104: 1812-21.
17. Roddie H, Klammer M, Thomas C,. Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia. Br J Haematol 2006; 133: 152-7.
18. Galea-Lauri J, Darling D, Mufti G,. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother 2002; 51: 299-310. (Pubitemid 34743982)
19. Galea-Lauri J, Wells JW, Darling D,. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Cancer Immunol Immunother 2004; 53: 963-97.
20. Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loisseau H, Harousseau JL, Meflah K, Gregoire M,. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Cancer Research 2002; 62: 2861-8. (Pubitemid 34525772)
21. Lee JJ, Hook H, Park MS,. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cells lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. J Clin Apheresis 2004; 19: 66-70.
22. Schmitt A, Reinhardt P, Hus I, Tabarkiewicz J, Roliñski J, Barth T, Giannopoulos K, Dmoszyñska A, Wiesneth M, Schmitt M,. Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia. Transfusion 2007; 47: 1588-94. (Pubitemid 47300602)
23. Royer PJ, Bougras G, Ebstein F, Leveque L, Tanguy-Royer S, Simon T, Juge-Morineau N, Chevallier P, Harousseau JL, Gregoire M,. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy. Exp Hematol 2008; 36: 329-39.
24. Hock BD, Haring LF, Ebbett AM, Patton WN, McKenzie JL,. Differential effects of G-CSF mobilization on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation. Bone Marrow Transplant 2002; 30: 733-40. (Pubitemid 36004300)
25. Shaughnessy PJ, Bachier C, Lemairstre CF, Akai C, Pollock BH, Gazzit Y,. Granulocyte colony-stimulating factor mobilizes more dendritic subsets than GM-CSF with no polarization of dendritic cell subsets in normal donors. Stem Cells 2006; 24: 1789-97. (Pubitemid 44474192)
26. Klangstinsirikul P, Russell NH,. Peripheral blood stem cell harvests from G-CSF stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 2002; 30: 495-501. (Pubitemid 34556742)
27. pos dendritic precursor cells. Br J Haematology 2004; 124: 636-44. (Pubitemid 38297097)
28. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T, Misawa S,. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911-8. (Pubitemid 27019637)
29. Zimmermann SY, Esser R, Rohrbach E, Klingebiel T, Koehl U,. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells. J Immunol Methods 2005; 296: 63-76. (Pubitemid 40174740)
30. Kim GG, Donnenberg VS, Donnenberg AD, Gooding W, Whiteside TL,. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes efector cells: comparisons to a 4 h 51Cr-release assay. J Immunol Methods 2005; 325: 51-66. (Pubitemid 47238289)
31. Sánchez-García J, Torres A, Herrera C, Alvarez MA,. Cell cycle kinetic changes induced by interleukin-3 and interleukin-6 during ex vivo expansion of mobilized peripheral blood CD34 cells. Haematologica 2006; 91: 121-4. (Pubitemid 43235394)
32. Van Driessche A, Van de Velde AL, Nijs G, Braeckman T, Stein B, De Vries JM, Berneman ZN, Van Tendeloo VF,. Clinical grade manufacturing of autologous mature RNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-scalating clinical trial. Cytotherapy 2009; 11: 653-68.
33. Draube A, Beyer M, Wolf J,. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells. Eur J Haematol 2008; 81: 281-8.
34. Lee JJ, Choi BH, Kang HK, Kim SK, Nam JH, Yang DH, Kim YK, Kim HJ, Chung IJ,. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocytes-derived dendritic cells from AML patients. Leuk Res 2008; 32: 1653-60.
35. Ferlazzo G, Wesa A, Wei WZ, Galy A,. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen specific CD8+ cells. J Immunol 1999; 163: 3597-606.
36. Osugi Y, Vuckovic S, Hart DN,. Myeloid blood CD11c+ dendritic cells and monocytes derived cells differ in their ability to stimulate T lymphocytes. Blood 2002; 100: 2858-66.
37. Ho CS, Munster D, Pyke CM, Hart DN, Lopez A,. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 2002; 99: 2897-904. (Pubitemid 34525379)
38. Schui DK, Singh L, Schneider B, Knau A, Hoelzer D, Weidmann E,. Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts. Leuk Res 2002; 26: 383-9. (Pubitemid 34143053)
39. Delluc S, Hachem P, Rusakiewicz S, Gasston A, Marchiol-Fournigault C, Tourneur L, Babchia N, Fradelizi D, Regnault A, Sang KH, Chiocchia G, Buzyn A,. Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long lasting T cell response. Cancer Immunol Immunother 2009; 58: 1669-77.